A 2023 analysis in the Journal of Clinical Endocrinology & Metabolism noted that GLP-1 agents can reduce stomach acid secretion and alter intestinal pH, both of which may influence absorption of various medications
38 Phase 3 trials in people with obesity (REDEFINE-1) or people with obesity plus T2D (REDEFINE-2), CagriSema achieved 20.4 per cent and 13.7 per cent weight loss respectively
Wondering if BPC 157 may be the right solution to help you lose weight
Here's what tracking does for you: Shows you how much protein you're actually eating Reveals hidden calories in drinks and condiments Helps you spot patterns that trigger nausea or side effects Keeps you accountable without feeling restrictive Provides data to share with your healthcare provider GLP-1 medications work best when combined with whole foods and adequate protein
Biochemical Pharmacology , 66 (8): 1499-1503 Timbrell, J
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al